Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Volta Medical
- Target Recruit Count
- 278
- Registration Number
- NCT06825104
- Locations
- 🇫🇷
CHU Lyon, Hôpital Louis Pradel, Bron, France
🇫🇷Pôle Santé République, Clermont-Ferrand, France
🇫🇷Hôpital Saint Philibert, Lomme, France
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
- Conditions
- Atrial FibrillationArrhythmias, CardiacAtrial Arrhythmia
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Volta Medical
- Target Recruit Count
- 150
- Registration Number
- NCT06083012
- Locations
- 🇫🇷
Hôpital Privé Jacques Cartier, Massy, France
🇫🇷Polyclinique Saint George, Nice, France
🇫🇷Centre Cardiologique du Nord, Saint-Denis, France
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Volta Medical
- Target Recruit Count
- 400
- Registration Number
- NCT06056271
- Locations
- 🇺🇸
Endeavor Health, Evanston, Illinois, United States
🇺🇸Kansas City Cardiac Arrhythmia Research LLC, Overland Park, Kansas, United States
🇺🇸Northwell Health, New York, New York, United States
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Volta Medical
- Target Recruit Count
- 92
- Registration Number
- NCT05477147
- Locations
- 🇺🇸
Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸Arrhythmia Research Group, Jonesboro, Arkansas, United States
🇺🇸Ascension St. Vincent's Hospital, Jacksonville, Florida, United States
AutoMatic disPERsion Tagging Function Preliminary Evaluation
- Conditions
- Atrial FibrillationAtrial TachycardiaAtrial Arrhythmia
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Volta Medical
- Target Recruit Count
- 40
- Registration Number
- NCT05362656
- Locations
- 🇫🇷
Hôpital Saint-Joseph, Marseille, France
- Prev
- 1
- 2
- Next
News
AI-Guided Cardiac Ablation Shows Superior Results in Landmark Persistent AF Trial
Volta Medical's AI-guided cardiac ablation combined with pulmonary vein isolation demonstrated 88% freedom from atrial fibrillation at 12 months, compared to 70% with standard treatment alone.
AI-Guided Ablation Shows Superior Results in Treating Persistent Atrial Fibrillation
A groundbreaking clinical trial demonstrates that AI-guided cardiac ablation combined with pulmonary vein isolation achieves 88% success rate in treating persistent atrial fibrillation, compared to 70% with standard treatment alone.
Clinical Trial Highlights: Advances in IPF, Diabetes, COPD, and Cancer Therapies
Arecor Therapeutics' AT278 demonstrated an accelerated PK/PD profile in overweight and obese individuals with Type 2 diabetes, showing promise for improved glucose control.